Literature DB >> 5365337

Reaction pattern to three stresses--electroplexy, surgery, and myocardial infarction--of fibrinolysis and plasma fibrinogen.

R Chakrabarti, E D Hocking, G R Fearnley.   

Abstract

The effects of three types of stress-electroplexy, surgery, and myocardial infarction-on blood fibrinolytic activity and plasma fibrinogen levels were studied in 10, eight, and six patients respectively. The fibrinolytic response to electroplexy consisted of an initial short increase followed in half the patients by reduced fibrinolytic activity lasting two to four days. After surgery and myocardial infarction normal fibrinolytic activity was followed by a period of reduced activity; the timing of the measurements on these patients may have precluded recognition of an initial increase in fibrinolysis similar to that following electroplexy. The fibrinolytic ;shutdown' which lasted for about 10 days in the coronary patients was evidently due to reduction of plasminogen activator, as judged by prolongation of the euglobulin lysis times as well as of the blood clot lysis times. Plasma fibrinogen levels rose in the surgical and coronary patients but not in the patients given electroplexy which indicates that fibrinolytic activity changes independently of plasma fibrinogen level. The results suggest that the fibrinolytic system exhibits a common reaction pattern to stress, irrespective of its nature and of tissue damage. They call for caution in assuming a specific causal association in acute diseases such as pancreatitis and haematemesis where similar fibrinolytic changes may be encountered.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5365337      PMCID: PMC474341          DOI: 10.1136/jcp.22.6.659

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  [Study of 2 types of fibrinolysis produced respectively by injection of a pyrogen & by electroshock].

Authors:  P A MAURICE
Journal:  Acta Haematol       Date:  1959-02       Impact factor: 2.195

2.  Variation in fibrinolytic activity after acute myocardial infarction and after the administration of oral anticoagulant drugs and intravenous heparin.

Authors:  H LACKNER; C MERSKEY
Journal:  Br J Haematol       Date:  1960-10       Impact factor: 6.998

3.  Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis.

Authors:  G R FEARNLEY; G BALMFORTH; E FEARNLEY
Journal:  Clin Sci       Date:  1957-11       Impact factor: 6.124

4.  Fibrinolysis in myocardial infarction.

Authors:  R HUME
Journal:  Br Heart J       Date:  1958-01

5.  [Electroshock and fibrinolysis].

Authors:  S P BERG
Journal:  Klin Wochenschr       Date:  1950-08-01

6.  Activation of blood clotting and inhibition of fibrinolysis in acute pancreatitis.

Authors:  A Gabryelewicz; S Niewiarowski
Journal:  Thromb Diath Haemorrh       Date:  1968-12-31

7.  Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol.

Authors:  G R Fearnley; R Chakrabarti
Journal:  Lancet       Date:  1966-10-08       Impact factor: 79.321

8.  Studies on the blood fibrinolytic enzyme system following acute myocardial infarction.

Authors:  N B Bennett; C M Ogston; D Ogston
Journal:  Clin Sci       Date:  1967-02       Impact factor: 6.124

9.  Methodological study and a recommended technique for determining the euglobulin lysis time.

Authors:  R Chakrabarti; M Bielawiec; J F Evans; G R Fearnley
Journal:  J Clin Pathol       Date:  1968-11       Impact factor: 3.411

10.  COAGULATION AND FIBRINOLYSIS IN INJURED PATIENTS.

Authors:  D INNES; S SEVITT
Journal:  J Clin Pathol       Date:  1964-01       Impact factor: 3.411

View more
  25 in total

1.  Letter: Fibrinolysis and venous thrombosis.

Authors:  I C Gordon-Smith; J A Hickman
Journal:  Br Med J       Date:  1975-03-08

2.  Letter: Fibrinolysis and venous thrombosis.

Authors:  G R Fearnley
Journal:  Br Med J       Date:  1975-01-25

Review 3.  Fibrinolysis Shutdown in Trauma: Historical Review and Clinical Implications.

Authors:  Hunter B Moore; Ernest E Moore; Matthew D Neal; Forest R Sheppard; Lucy Z Kornblith; Dominik F Draxler; Mark Walsh; Robert L Medcalf; Mitch J Cohen; Bryan A Cotton; Scott G Thomas; Christine M Leeper; Barbara A Gaines; Angela Sauaia
Journal:  Anesth Analg       Date:  2019-09       Impact factor: 5.108

4.  Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient.

Authors:  Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Angela Sauaia; Anirban Banerjee; Christopher C Silliman
Journal:  Transfusion       Date:  2016-04       Impact factor: 3.157

5.  Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?

Authors:  Hunter B Moore; Ernest E Moore; Michael P Chapman; Kirk C Hansen; Mitchell J Cohen; Frederic M Pieracci; James Chandler; Angela Sauaia
Journal:  J Am Coll Surg       Date:  2019-03-29       Impact factor: 6.113

Review 6.  Fibrinolysis in trauma: a review.

Authors:  M J Madurska; K A Sachse; J O Jansen; T E Rasmussen; J J Morrison
Journal:  Eur J Trauma Emerg Surg       Date:  2017-09-16       Impact factor: 3.693

7.  Interleukin-6 and coagulation-fibrinolysis fluctuations after laparoscopic and conventional cholecystectomy.

Authors:  G Vander Velpen; F Penninckx; R Kerremans; J Van Damme; J Arnout
Journal:  Surg Endosc       Date:  1994-10       Impact factor: 4.584

8.  Haematological stress syndrome in atherosclerosis.

Authors:  J Stuart; A J George; A J Davies; A Aukland; R A Hurlow
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

9.  Immune responses to the cleavage-associated neoantigens of fibrinogen in man. Identification and characterization of humoral antibodies specific for cleavage fragments.

Authors:  E F Plow; T S Edgington
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

10.  [Stress-metabolism after myocardial infarction-demonstrated by means of the behaviour of plasma proteins with short half-life (author's transl)].

Authors:  G Ollenschläger; H Gofferje; L Horbach; H Prestele; K Schultis
Journal:  Klin Wochenschr       Date:  1981-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.